My Ultimate Sign-in System Made Me Invincible Chapter 492 Countries Sending Official Observer Status Requests

The training session was brief yet enjoyable, yielding substantial benefits for the entire crew. Liam’s companions gained firsthand insight into the capabilities of someone immensely powerful; it moved beyond mere theoretical knowledge to a visceral understanding, forged through repeated, structured defeats that felt more like lessons than an ego-crushing ordeal.

Matt emerged as the primary beneficiary, having secured his own private space shuttle after enduring nearly five minutes of what any sane person would call a life-threatening beating. The fact that he was already consumed with planning the Titanium Eagle’s interior layout during the journey home served as proof that his priorities remained entirely intact, despite having been knocked unconscious moments earlier.

As the group traversed the Atlantic, they exchanged thoughts over their exosuits' comms system, revisiting highlights from the training with the nostalgic warmth typically found only among survivors of a shared trauma.

"I honestly struggle to believe you faced all of us without even activating your exosuit," Harper noted, his tone laced with a disbelief that had fermented since they departed Antarctica. "You stood there in street clothes the whole time. In temperatures reaching negative forty degrees. While we were encased in top-tier powered armor."

Alex let out a chuckle, the sound distorted by a light hiss through the communications channel. "I suppose someone capable of manifesting shockwaves just by moving doesn’t truly require an exosuit. At this stage, the suit would probably just hold him back."

"He has a point," Kristopher chimed in contemplatively. "The exosuit elevates standard human specs to superhuman grades. But if you're already functioning at a level that makes the superhuman seem ordinary, what could a suit possibly provide?"

Stacy’s voice bubbled with curiosity. "I’m just trying to visualize the kind of existential threat that would actually force Liam to deploy his exosuit. Like, what would that even resemble? What power level exists that makes Liam in his base state insufficient?"

"Probably something on the scale of a deity," Alex mused, his tone holding more than just idle speculation. "A literal divine entity. An ancient demon. A cosmic horror spawned from outside reality. That is likely the threshold where Liam thinks, 'alright, maybe it's time to put the armor on for this one.'"

Liam’s laughter echoed through the comms, sincere and warm despite the absurdity of the premise. "I appreciate the vote of confidence, but I’m nowhere near sturdy enough to contend with an actual god. If I stumbled upon something of that magnitude, I’d be reduced to dust in a heartbeat. The exosuit wouldn’t change that—it would simply ensure I was slightly more expensive dust."

The group went quiet briefly, letting the weight of his words sink in.

"I refuse to accept that," Kristy stated firmly. "You just rendered Matt unconscious with a single blow while blatantly holding back. You moved at speeds that defied our enhanced vision. You possess spacecraft, lunar outposts, and physics-defying tech. And you’re telling us there are entities out there that could instantly wipe you out?"

"There are many," Liam affirmed, his voice sounding matter-of-fact rather than fearful. "The universe is significantly more vast and lethal than Earth’s current models suggest. What seems overwhelmingly potent from one angle is often pitifully inadequate from another. My strength is impressive by human standards, sure. But when measured against the broader scale of reality? I’m still firmly in the phase of 'trying not to be eradicated by cosmic threats.'"

Matt, who had remained silent since the return flight began—likely still recovering from a concussion—spoke up with his typical vigor. "That is somehow both terrifying and exhilarating. Like, we’re already operating at levels that seemed purely impossible, and you’re implying there are entire echelons of power beyond that?"

"Many echelons," Liam replied. "Countless tiers. It’s quite humbling, in truth."

The discourse continued as they drifted through the air, the Atlantic Ocean stretching below in a blurry tapestry of deep water and white-capped waves. Their exosuit HUDs meticulously tracked their progress, displaying arrival times and flight paths designed to steer clear of commercial air traffic.

Upon entering U.S. airspace, they surged in speed; their stealth measures ensured that despite hitting velocities that would have scrambled military radar if noticed, they remained entirely invisible to sensors, satellites, and the naked eye.

The eastern seaboard illuminated their displays, the urban sprawling creating constellations of light visible from their altitude. As they neared their respective drop-off points, the group disbanded, exchanging quick goodbyes and promises to revisit the topic another time.

Matt was the final member to peel away, his flight trajectory wavering like he was still shaking off the remnants of his knockout. His friends watched him retreat with a blend of concern and amusement, certain the exosuit’s flight auto-pilot would keep him from colliding with a tower, though they were less certain about his decision-making upon landing.

Liam watched his friends disperse, a faint smirk lingering on his face, before he adjusted his path toward the Bellemere Mansion.

***

The Swiss Mission to the United Nations was housed in a modern Manhattan skyscraper, and at exactly 9:47 AM Eastern Time—timed perfectly to show dedication without appearing desperate—Ambassador Friedrich Müller hand-delivered a formal petition to the U.S. State Department, intended for forwarding to Nova Technologies.

The request arrived immaculately prepared on crisp, official letterhead, complete with documentation implying the Swiss bureaucracy had pulled an all-nighter to finalize it.

SWISS CONFEDERATION

Federal Department of Foreign Affairs

Permanent Mission to the United Nations

Official Request for Observer Status

Re: Nova Technologies Medical Nanite Clinical Trial

To Whom It May Concern at Nova Technologies:

The Swiss Confederation formally petitions for authorization to dispatch qualified medical observers to witness the Medical Nanite clinical trials announced on [date]. Switzerland proposes a delegation composed of:

- Two physicians specializing in neurology and regenerative medicine

- One expert in bioethics

- One representative from the Swiss Agency for Therapeutic Products

Our delegates would operate strictly in an observational capacity, with no expectation of gaining access to proprietary secrets or confidential methodologies. We seek only to witness the trial protocols and outcomes mentioned in your public communiqué.

Switzerland acknowledges that Nova Technologies is under no compulsion to facilitate such oversight, and we are grateful for your consideration. We are prepared to operate within any framework you deem appropriate for observer access.

We respectfully seek clarity on these points:

1. Will observer access be prioritized based on arrival, or will specific selection criteria be utilized?

2. What is the anticipated timeline for trial initiation and observer notification?

3. Will observers be permitted to record findings, or will confidentiality clauses restrict such activity?

4. Are there caps on the number of observers per nation, or can multiple delegations be accommodated?

We value your time and attention.

Respectfully submitted,

Ambassador Friedrich Müller

Permanent Representative of Switzerland to the United Nations

***

The request filtered into the State Department’s Bureau of Economic and Business Affairs within an hour, where it was immediately branded high-priority, given the institutional chaos surrounding Nova Technologies.

By noon, seventeen additional nations had submitted similar petitions.

Singapore’s approach was characteristically blunt and efficient, a one-page document that shed any veneer of diplomatic fluff to state their interest plainly:

REPUBLIC OF SINGAPORE

Ministry of Health

We request four observer slots for the Medical Nanite trials. Our team will include clinical specialists in oncology and neural regeneration. We realize this is a unique request for unique technology. We are ready to meet any reasonable mandates Nova Technologies sets.

Key questions:

- Selection timeline?

- Required credentials for medical staff?

- Restrictions on reporting?

We look forward to Nova Technologies’ consideration and value a productive partnership.

***

The United Kingdom’s plea arrived from their Washington embassy, channeled through the Foreign, Commonwealth & Development Office using the sort of polished, formal language British bureaucrats have refined over centuries:

FOREIGN, COMMONWEALTH & DEVELOPMENT OFFICE

His Majesty’s Government

His Majesty’s Government respectfully petitions for observer participation in the Medical Nanite trials. The UK proposes sending representatives from the National Health Service and the Medicines and Healthcare products Regulatory Agency.

While we recognize Nova Technologies classifies regulatory presence as optional, we believe that, given the implications of this technology for global welfare, transparent observation serves both your interests and the public good.

We seek clarification on several procedural points:

1. What metrics will Nova Technologies prioritize when selecting observers?

2. Will observers be compelled to sign NDAs, and what are the specific scopes of those restrictions?

3. Are observers permitted to publish findings post-trial, or does such a release require prior authorization?

4. Will the site of the off-world facility be disclosed beforehand, or will its location remain classified?

We value your consideration and look forward to engagement.

***

The European Union contacted the firm through multiple vectors—the EU UN delegation, separate member embassies, and a direct inquiry from the European Medicines Agency:

EUROPEAN MEDICINES AGENCY

European Union

The European Medicines Agency requests observer status for medical professionals from EU member states. We understand these trials are occurring outside conventional regulatory spheres.

However, we hold that oversight serves several public interests:

- Verification of protocols

- Assessment of efficacy

- Documentation of methodologies

- Evaluation for healthcare integration

We recognize Nova Technologies is under no obligation to accommodate us. This is a request for cooperation, not an assertion of authority.

Questions requiring answers:

1. Will observers be picked by region, or can individual members apply?

2. What liability protections will be afforded to observers at an off-world site?

3. Will observers have access to patient histories and monitoring data?

4. Is interaction with participants allowed, or is oversight strictly passive?

We await your response and stay open to your framework.

***

By the closing bell of the business day, forty-three nations had formally applied for observer roles, ranging from global forces to smaller states aware that being present for a historic medical breakthrough was a strategic necessity.

The petitions varied in tone—from Swiss professionalism to Singapore’s bluntness, down to the almost pleading language of smaller nations hoping for a chance—but they all shared a careful threading of the needle: they showed interest without ever claiming authority over Nova Technologies.

Every submission hinted, either directly or via omission, that they were beggars, not owners. The power dynamic had been finalized by Nova’s announcements, and the governments were simply adapting.

The State Department collated the requests, attached a summary noting the global diversity of the applicants, and prepped the package for the Whitlock back-channel, the recognized path for diplomatic traffic.

While those nations could have mailed the requests directly, it would have invited friction with the U.S. government, especially given the sensitivity regarding the links between Whitlock, JP Morgan, and Nova Technologies.

Before the State Department could transmit the bundle, an email pinged into their inbox directly from Nova Technologies’ official communications channel.

The content was brief:

We have noted the international interest regarding observer roles for the Medical Nanite trials. A formal response addressing selection, criteria, and logistics will be broadcast within 72 hours. All nations that submitted petitions will be notified individually.

All questions posed by observer requests will be answered in the forthcoming announcement.

- Nova Technologies Communications

The State Department official responsible for the inbox sat back, reading the text thrice to ensure it was understood correctly.

Nova Technologies was tracking the requests in real-time. They had likely seen the documents before the State Department finished compiling them. And clearly, they intended to bypass diplomats entirely and talk to each nation directly.

It was another understated display of the same principle that defined Nova’s communication: they treated governments as peers, not as superiors.

She forwarded the alert to her manager with a single, blunt line: They’re watching everything. Responding in 72 hours. No intermediaries necessary.

Her boss read the update, hit reply with a short, "Noted. This is the new normal," and tucked the exchange into the ever-expanding folder marked "Nova Technologies: Institutional Adaptation."

Because that’s exactly what this was. A fundamental change in how global bodies would function when dealing with an actor whose reach, capabilities, and sovereignty eclipsed most modern nations.

The requests would be addressed. Observers would be picked. Trials would proceed.

But everything would adhere to Nova Technologies’ schedule, their metrics, and their rules.

The governments petitioning them realized this. The diplomats drafting the requests realized this. The clerks pushing the papers realized this.

Awareness, however, didn't make the transition any less jarring. It merely rendered the adjustment slightly more bearable.

Across hundreds of bureaus, officials waited on Nova’s next move, knowing whatever template they established would dictate how power—both institutional and clinical—would be redefined in the new era.